has been cited by the following article(s):
[1]
|
Probing the Mechanism of Action of Cry41Aa on HepG2 through the Establishment of a Resistant Subline
Toxins,
2022
DOI:10.3390/toxins14050319
|
|
|
[2]
|
Decellularized Matrix Produced by Mesenchymal Stem Cells Modulates Growth and Metabolic Activity of Hepatic Cell Cluster
ACS Biomaterials Science & Engineering,
2018
DOI:10.1021/acsbiomaterials.7b00494
|
|
|
[3]
|
Decellularized Matrix Produced by Mesenchymal Stem Cells Modulates Growth and Metabolic Activity of Hepatic Cell Cluster
ACS Biomaterials Science & Engineering,
2018
DOI:10.1021/acsbiomaterials.7b00494
|
|
|
[4]
|
Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapy
European Journal of Pharmacology,
2017
DOI:10.1016/j.ejphar.2017.09.035
|
|
|
[5]
|
FTIR microspectroscopy defines early drug resistant human hepatocellular carcinoma (HepG2) cells
Experimental Cell Research,
2016
DOI:10.1016/j.yexcr.2015.12.007
|
|
|
[6]
|
Indirubin 3′-( O -oxiran-2-ylmethyl)oxime: A novel anticancer agent
Bioorganic & Medicinal Chemistry Letters,
2015
DOI:10.1016/j.bmcl.2015.02.053
|
|
|
[7]
|
Indirubin 3′-(O-oxiran-2-ylmethyl)oxime: A novel anticancer agent
Bioorganic & Medicinal Chemistry Letters,
2015
DOI:10.1016/j.bmcl.2015.02.053
|
|
|